logo
  

VNET Group Announces Strategic Investment From SDHG - Quick Facts

VNET Group, Inc. (VNET) announced that Success Flow International Investment Limited and Choice Faith Group Holdings Limited have entered into an investment agreement with VNET to make an equity investment in an aggregate amount of $299 million in the company. Success Flow and Choice Faith are beneficially owned by Shandong Hi-Speed Holdings Group.

Success Flow will make an equity investment of $209.3 million by subscribing for 455,296,932 newly issued Class A ordinary shares. Choice Faith will make an equity investment of $89.7 million by subscribing for 195,127,260 newly issued Class A ordinary shares. Immediately after the closing of the proposed investment, Success Flow and Choice Faith will hold approximately 29.5% and 12.6% of the total issued and outstanding shares of VNET Group.

Success Flow and Choice Faith also entered into an investor rights agreement with VNET and a voting and consortium agreement with Josh Sheng Chen, Founder and Executive Chairman of VNET, and his affiliated investment vehicles.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AbbVie (ABBV) Monday announced a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals, a clinical stage neuroscience biotech firm, to develop next-generation treatment approaches and unmet needs in psychiatric disorders. AbbVie noted that the first-generation compounds may... Healthwest Minerals, Inc. d/b/a Mt. Capra Products has recalled 1,506 boxes of Goat Milk Formula Recipe Kit, also urging consumers to immediately discontinue use of the product as infant formula. The firm does not recommend using this product for infants from 0-12 months of age. Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
RELATED NEWS
Follow RTT